The company has since learned the cyberattack was caused by a third-party contractor’s user session within its cloud-based system being compromised.

Xeltis has reached over 50% enrolment in its US pivotal trial of aXess, a vascular access device designed for adults with end-stage renal disease who require haemodialysis.

Tissium will now bring COAPTIUM CONNECT, the first atraumatic peripheral nerve repair surgical system, to patients in the US.

Hyperfine has commercially launched its next-generation Swoop portable MRI system (Model 2) in select European markets.

Experts at HLTH Europe 2026 agreed that healthcare innovations won't meet their full potential until healthcare services can implement them.

Artivion has received the PMA clearance from the US FDA for AMDS Hybrid Prosthesis device, permitting its use in treating acute DeBakey Type I aortic dissections with clinical or radiographic ...

Aurenar’s V-Link system uses transauricular vagus nerve stimulation to modulate brain inflammation in patients that have experienced a stroke.

Funds will support Materna’s completion of a pivotal trial evaluating its system for reducing pelvic floor muscle injury during childbirth, as well as other commercial activities.

Medicina supplied devices bearing false CE markings to healthcare providers including National Health Service (NHS) Trusts across the UK.

The initiative is designed to simplify the ability for GE HealthCare customers with existing interventional suites to access new technologies.

Quest Diagnostics has received approval from the NYSDOH CLEP for its Haystack MRD test, expanding its use to cancer patients throughout the US.

OrthAlign has completed the first clinical procedures using its Lantern ASC system, designed for the ASC setting.